Avid Bioservices, Inc. Quarterly Costs and Expenses in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Avid Bioservices, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q3 2023.
  • Avid Bioservices, Inc. Costs and Expenses for the quarter ending October 31, 2023 was $6.56M, a 4.01% decline year-over-year.
  • Avid Bioservices, Inc. Costs and Expenses for the twelve months ending October 31, 2023 was $27.5M.
  • Avid Bioservices, Inc. annual Costs and Expenses for 2022 was $27.9M, a 31.3% increase from 2021.
  • Avid Bioservices, Inc. annual Costs and Expenses for 2021 was $21.2M, a 24.4% increase from 2020.
  • Avid Bioservices, Inc. annual Costs and Expenses for 2020 was $17.1M, a 14.7% increase from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $27.5M $6.56M -$274K -4.01% Aug 1, 2023 Oct 31, 2023 10-Q/A 2024-04-24
Q2 2023 $27.8M $6.26M -$119K -1.87% May 1, 2023 Jul 31, 2023 10-Q/A 2024-04-24
Q1 2023 $27.9M $7.56M Feb 1, 2023 Apr 30, 2023 10-K/A 2024-04-24
Q4 2022 $7.11M Nov 1, 2022 Jan 31, 2023 10-K/A 2024-04-24
Q3 2022 $6.83M Aug 1, 2022 Oct 31, 2022 10-K/A 2024-04-24
Q2 2022 $6.38M May 1, 2022 Jul 31, 2022 10-K/A 2024-04-24
Q1 2018 $17.7M -$24.6M -$9.61M -64.1% Feb 1, 2018 Apr 30, 2018 10-K 2020-06-30
Q4 2017 $27.3M $4.82M +$459K +10.5% Nov 1, 2017 Jan 31, 2018 10-Q 2018-03-12
Q3 2017 $26.9M $9.18M -$2.83M -23.6% Aug 1, 2017 Oct 31, 2017 10-Q 2017-12-11
Q2 2017 $29.7M $28.3M +$11.6M +69.6% May 1, 2017 Jul 31, 2017 10-Q 2017-09-11
Q1 2017 $18.1M -$15M +$37.5M +71.4% Feb 1, 2017 Apr 30, 2017 10-K 2019-06-27
Q4 2016 -$19.4M $4.37M -$19.2M -81.5% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-12
Q3 2016 -$171K $12M -$11.3M -48.6% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-11
Q2 2016 $11.2M $16.7M -$6.73M -28.7% May 1, 2016 Jul 31, 2016 10-Q 2017-09-11
Q1 2016 $17.9M -$52.4M -$73.9M -344% Feb 1, 2016 Apr 30, 2016 10-K 2018-07-16
Q4 2015 $91.8M $23.6M +$4.88M +26.1% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-13
Q3 2015 $86.9M $23.3M +$4.91M +26.6% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-12
Q2 2015 $82M $23.4M +$4.76M +25.5% May 1, 2015 Jul 31, 2015 10-Q 2016-09-08
Q1 2015 $77.3M $21.5M +$4.47M +26.3% Feb 1, 2015 Apr 30, 2015 10-K 2017-07-14
Q4 2014 $72.8M $18.7M +$5.07M +37.2% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-09
Q3 2014 $67.7M $18.4M +$3.27M +21.6% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-10
Q2 2014 $64.5M $18.7M +$6.36M +51.7% May 1, 2014 Jul 31, 2014 10-Q 2015-09-09
Q1 2014 $58.1M $17M +$4.29M +33.7% Feb 1, 2014 Apr 30, 2014 10-K 2016-07-14
Q4 2013 $53.8M $13.6M +$1.43M +11.7% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-12
Q3 2013 $52.4M $15.2M +$1.97M +14.9% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-10
Q2 2013 $50.4M $12.3M +$386K +3.24% May 1, 2013 Jul 31, 2013 10-Q 2014-09-09
Q1 2013 $50M $12.7M -$238K -1.84% Feb 1, 2013 Apr 30, 2013 10-K 2015-07-14
Q4 2012 $50.3M $12.2M -$2.17M -15.1% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-07
Q3 2012 $52.4M $13.2M -$3.07M -18.9% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-10
Q2 2012 $55.5M $11.9M -$1.78M -13% May 1, 2012 Jul 31, 2012 10-Q 2013-09-09
Q1 2012 $57.3M $13M +$272K +2.15% Feb 1, 2012 Apr 30, 2012 10-K 2014-07-14
Q4 2011 $57M $14.4M +$2.65M +22.6% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-12
Q3 2011 $54.4M $16.3M +$3.22M +24.7% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-10
Q2 2011 $51.2M $13.7M +$2.99M +27.8% May 1, 2011 Jul 31, 2011 10-Q 2012-09-10
Q1 2011 $48.2M $12.7M Feb 1, 2011 Apr 30, 2011 10-K 2013-07-11
Q4 2010 $11.7M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-09
Q3 2010 $13M Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-12
Q2 2010 $10.7M May 1, 2010 Jul 31, 2010 10-Q 2011-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.